摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5,7-dihydroxy-2-oxo-2H-chromen-4-yl)-acetic acid | 92422-76-9

中文名称
——
中文别名
——
英文名称
(5,7-dihydroxy-2-oxo-2H-chromen-4-yl)-acetic acid
英文别名
(5,7-Dihydroxy-2-oxo-2H-chromen-4-yl)-essigsaeure;4-Carboxymethyl-5,7-dihydroxy-cumarin;2-(5,7-dihydroxy-2-oxo-2H-chromen-4-yl)acetic acid;2-(5,7-dihydroxy-2-oxochromen-4-yl)acetic acid
(5,7-dihydroxy-2-oxo-2<i>H</i>-chromen-4-yl)-acetic acid化学式
CAS
92422-76-9
化学式
C11H8O6
mdl
MFCD02673810
分子量
236.181
InChiKey
WVYIHVIEQRZMLS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    620.3±43.0 °C(Predicted)
  • 密度:
    1.638±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    104
  • 氢给体数:
    3
  • 氢受体数:
    6

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and rat lens aldose reductase inhibitory activity of some benzopyran-2-ones
    作者:Abram N. Brubaker、Jack De Ruiter、William L. Whitmer
    DOI:10.1021/jm00156a031
    日期:1986.6
    A number of 4,7-disubstituted benzopyran-2-ones were synthesized and evaluated for crude rat lens aldose reductase inhibitory activity. Substituents on position 4 included CH3, CO2H, CH2CO2H, CH = CHCO2H, and CH2CH2CO2H. The aromatic substituents included OH, OCH3, OCOCH3, CH2CH3, and Cl. Also included in the study were 3-oxo-3H-naphtho[2,1-b]pyran-1-acetic, 2-oxo-2H-naphtho[1,2-b]pyran-4-acetic, and 1-naphthylacetic acids. The benzopyran and naphthopyran derivatives were prepared by the classical von Pechmann reaction. General structure-activity relationships reveal that optimal enzyme inhibitory activity is displayed by those compounds possessing the acetic acid moiety. For example, the most potent derivative, 3-oxo-3H-naphtho[2,1-b]pyran-1-acetic acid with an IC50 of 0.020 microM, is as potent as sorbinil (IC50 = 0.017 microM) in the crude rat lens aldose reductase assay.
  • PAPD5 INHIBITORS AND METHODS OF USE THEREOF
    申请人:Children`s Medical Center Corporation
    公开号:US20210177827A1
    公开(公告)日:2021-06-17
    The disclosure relates to compounds that are, e.g., PAP Associated Domain Containing 5 (PAPD5) inhibitors and methods of use thereof.
  • Dey, Journal of the Chemical Society, 1915, vol. 107, p. 1637
    作者:Dey
    DOI:——
    日期:——
查看更多